Stock Analysis - Danaher Corp (DHR)

As with every international business, Danaher’s operations are exposed to foreign currency risk and geopolitical issues as well as regulatory entities, especially in the Healthcare sectors. Changes in politics, regulations, or laws could potentially impact the business of Danaher Corp.

Conclusion

With a 50.9 PE Ratio, Danaher is very richly valued but looking at the whole sector, the US Medical Equipment industry has currently an average PE ratio of 53.1. Despite the valuation, I would consider increasing my position at the current levels since the combination of dividend growth and capital appreciation paired with their long success stories make for an interesting investment case.

There are a couple of companies that seem to never go on sale (Roper Technologies NYSE: ROP comes to mind) and Danaher fits right in this spectrum. In my honest opinion, I see a bright future for this company given the amount of innovation and potential in the healthcare and environmental sector.

As always, I recommend potential investors browse through the documents found on Danaher’s investor relations page as a great start for your due diligence.

Thank you for taking a look at my stock analysis of Danaher Corporation. I invite you to share any feedback you have to offer to help me improve future stock analysis and research!

1 2 3 4
View single page >> |

Disclaimer: I do hold a position in Danaher Corporation (NYSE: DHR). In 2020 it has emerged as one of my biggest holdings in the healthcare ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Harry Goldstein 2 months ago Member's comment

Good analysis on $DHR, thanks.

Just-Dividends 2 months ago Author's comment

Thank you for the kind words